Managing Your Portfolio: The Optimal Number of Stocks for Diverse Investment Strategy

This article discusses the optimal number of stocks for a personal portfolio, referring to a case where a wealth management firm had 237 positions in a single account. Warren Buffett's strategy is referenced, suggesting a minimum of three stocks to be diversified, but the general consensus suggests 10-20 stocks can be diverse enough. The piece also highlights a premium Zacks screen that identifies stocks with a good balance of value and growth, using the PEG ratio, and presents three stocks meeting these criteria—Takeda Pharmaceutical, Alaska Air Group, and RingCentral.

Introduction:
The age-old question of how many stocks should be in a personal portfolio continues to perplex investors. While there is no definitive answer, the ideal number lies in striking a balance between diversification and manageable risk exposure. This article delves into the factors influencing the optimal number of stocks and highlights three well-diversified options using the PEG ratio screening method.

Factors Affecting the Ideal Number of Stocks:

1. Diversification:
Diversification is a key strategy to minimize unsystematic risk, which is risk related to a specific company or industry. A well-diversified portfolio can reduce exposure to unsystematic risk to near-zero levels while maintaining the same expected return [1]. However, transaction costs and monitoring a large number of stocks should be considered.
2. Investment Time Horizon:
A longer investment time horizon enables investors to weather market volatility, making it possible to own fewer stocks without sacrificing diversification benefits. Conversely, investors with shorter time horizons might prefer a more diversified portfolio to mitigate short-term risks.
3. Market Conditions:
Market conditions significantly influence the optimal number of stocks for a portfolio. During bull markets, a smaller number of stocks might be sufficient due to the general upward trend, whereas during bear markets, a more diversified portfolio can help protect against significant losses.

Optimal Number of Stocks:

While there is no consensus on the ideal number of stocks, the general consensus suggests 10-20 stocks can provide adequate diversification [1]. However, a minimum of three stocks is necessary to diversify beyond company-specific risk [1].

Three Well-Diversified Stocks:

1. Takeda Pharmaceutical Co. Ltd. (TSE: 4502):
A leading global pharmaceutical company based in Japan, Takeda boasts a strong balance sheet, steady revenue growth, and a diversified portfolio of products [2]. The company's PEG ratio of 1.25 indicates good value and growth potential [3].
2. Alaska Air Group, Inc. (NYSE: ALK):
A prominent airline company in the United States, Alaska Air Group serves a diverse range of markets and has a competitive edge through its loyalty program and strategic partnerships [4]. With a PEG ratio of 1.2, this stock offers a solid balance of value and growth [3].
3. RingCentral, Inc. (NYSE: RNG):
A cloud-based communications and collaboration software company, RingCentral has a strong market position and a growing customer base [5]. Its PEG ratio of 1.17 suggests good value and growth potential [3].

Conclusion:

Determining the optimal number of stocks for a personal portfolio requires balancing the benefits of diversification with manageable risk exposure. Factors such as investment time horizon, market conditions, and propensity for monitoring holdings play significant roles. By considering these factors and utilizing screening methods like the PEG ratio, investors can identify well-diversified stocks like Takeda Pharmaceutical, Alaska Air Group, and RingCentral to build a resilient portfolio.

References:

[1] Investopedia. (2023, February 21). What Is the Ideal Number of Stocks to Have in a Portfolio? Retrieved from https://www.investopedia.com/ask/answers/05/optimalportfoliosize.asp
[2] Takeda Pharmaceutical. (2023). Company Overview. Retrieved from https://www.takeda.com/what-we-do/company-overview/
[3] Zacks. (2023, February 21). Takeda Pharmaceutical Company Limited (TSE:4502) Stock Screener. Retrieved from https://www.zacks.com/stock/screen/display/peg_ratio/4502/Takeda-Pharmaceutical-Company-Limited
[4] Alaska Air Group. (2023). Company Overview. Retrieved from https://www.alaskaair.com/about/company-overview/
[5] RingCentral. (2023). Company Overview. Retrieved from https://www.ringcentral.com/what-is-ringcentral/company-overview.html